Takeda is promoting U.S. chief Julie Kim to be its next CEO. AstraZeneca and Daiichi's Enhertu has won an FDA nod to expand into HER2-ultralow breast cancer. East Asian Americans are ...
So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...
League of Legends' newest Season 25 patch is finally here. This update will stop Wukong, Skarner and Viego from terrorizing the jungle, revitalize the Dominatio ...
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...
Welcome to Fierce Pharma's regulatory tracker for the first half of 2025. On this page, we're recording the regulatory progress of in-market products, including expansions into key geographies and ...
Providence reaches tentative agreement with some striking providers; broader Oregon strike continues
Though the broader strike continues, Providence has reached a tentative agreement with two of the 11 bargaining units participating in Oregon's largest healthcare strike. The terms—which come a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback